CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Global Ichiban Convertible Note	Bellridge Convertible Note	Preferred Stock Series A Preferred Stock	Preferred Stock Series 1A Preferred Stock	Common Stock	Common Stock Global Ichiban Convertible Note	Common Stock Bellridge Convertible Note	Additional Paid-In Capital	Additional Paid-In Capital Global Ichiban Convertible Note	Accumulated Deficit
Beginning balance at Dec. 31, 2019	$ (25,106,781)			$ 5		$ 475,917			$ 397,817,526		$ (423,400,229)
Beginning balance (in shares) at Dec. 31, 2019				48,100		4,759,161,650
Net Income (Loss)	6,392,193										6,392,193
Ending balance at Mar. 31, 2020	(18,714,588)			$ 5		$ 475,917			397,817,526		(417,008,036)
Ending balance (in shares) at Mar. 31, 2020				48,100		4,759,161,650
Beginning balance at Dec. 31, 2019	(25,106,781)			$ 5		$ 475,917			397,817,526		(423,400,229)
Beginning balance (in shares) at Dec. 31, 2019				48,100		4,759,161,650
Net Income (Loss)	5,035,232
Ending balance at Jun. 30, 2020	(20,024,417)			$ 5		$ 523,049			397,817,526		(418,364,997)
Ending balance (in shares) at Jun. 30, 2020				48,100		5,230,490,450
Beginning balance at Mar. 31, 2020	(18,714,588)			$ 5		$ 475,917			397,817,526		(417,008,036)
Beginning balance (in shares) at Mar. 31, 2020				48,100		4,759,161,650
Interest and Dividend Expense paid with Common Stock	2,132					$ 2,132
Interest and dividend expense paid with common stock (in shares)						21,328,800
Conversion of shares			$ 45,000					$ 45,000
Conversion of shares (in shares)								450,000,000
Net Income (Loss)	(1,356,961)										(1,356,961)
Ending balance at Jun. 30, 2020	(20,024,417)			$ 5		$ 523,049			397,817,526		(418,364,997)
Ending balance (in shares) at Jun. 30, 2020				48,100		5,230,490,450
Beginning balance at Dec. 31, 2020	(20,192,203)			$ 5		$ 1,810,258			399,780,319		(421,782,785)
Beginning balance (in shares) at Dec. 31, 2020				48,100	1,300	18,102,583,473
Proceeds from issuance of Series 1A Preferred Stock	2,500,000								2,500,000
Proceeds from issuance of Series 1A Preferred Stock (in shares)					2,500
Proceeds from issuance of Common Stock	3,000,000					$ 7,500			2,992,500
Proceeds from issuance of Common Stock (in shares)						75,000,000
Conversion of shares		$ 5,800,000					$ 16,800			$ 5,783,200
Conversion of shares (in shares)							168,000,000
Relieved on Conversion of Derivative Liability	1,686,079								1,686,079
Net Income (Loss)	1,846,384										1,846,384
Ending balance at Mar. 31, 2021	(5,359,740)			$ 5		$ 1,834,558			412,742,098		(419,936,401)
Ending balance (in shares) at Mar. 31, 2021				48,100	3,800	18,345,583,473
Beginning balance at Dec. 31, 2020	(20,192,203)			$ 5		$ 1,810,258			399,780,319		(421,782,785)
Beginning balance (in shares) at Dec. 31, 2020				48,100	1,300	18,102,583,473
Net Income (Loss)	153,445
Ending balance at Jun. 30, 2021	(7,052,679)			$ 5		$ 1,834,558			412,742,098		(421,629,340)
Ending balance (in shares) at Jun. 30, 2021				48,100	3,800	18,345,583,473
Beginning balance at Mar. 31, 2021	(5,359,740)			$ 5		$ 1,834,558			412,742,098		(419,936,401)
Beginning balance (in shares) at Mar. 31, 2021				48,100	3,800	18,345,583,473
Net Income (Loss)	(1,692,939)										(1,692,939)
Ending balance at Jun. 30, 2021	$ (7,052,679)			$ 5		$ 1,834,558			$ 412,742,098		$ (421,629,340)
Ending balance (in shares) at Jun. 30, 2021				48,100	3,800	18,345,583,473